Somatostatin-receptor 2 (sst(2))-mediated effects of endogenous somatostatin on exocrine and endocrine secretion of the rat stomach

Por Fykse, Vidar, Coy, David H, Waldum, Helge Lyder, Sandvik, Arne Kristian
Publicado em 2005

Examination of somatostatin involvement in the inhibitory action of GIP, GLP-1, amylin and adrenomedullin on gastric acid release using a new SRIF antagonist analogue

Por Rossowski, Wojciech J, Cheng, Beng-L, Jiang, Ning-Y, Coy, David H
Publicado em 1998

The Histone Deacetylase Inhibitor Vaproic Acid Induces Cell Growth Arrest in Hepatocellular Carcinoma Cells via Suppressing Notch Signaling

Por Sun, Guangchun, Mackey, Lily V., Coy, David H., Yu, Cui-Yun, Sun, Lichun
Publicado no J Cancer (2015)

Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells

Por Moody, Terry W., Mantey, Samuel A., Fuselier, Joseph A., Coy, David H., Jensen, Robert T.
Publicado em 2007

Targeted Chemotherapy Using a Cytotoxic Somatostatin Conjugate to Inhibit Tumor Growth and Metastasis in Nude Mice

Por Sun, Li-Chun, Mackey, L. Vienna, Luo, Jing, Fuselier, Joseph A., Coy, David H.
Publicado em 2008

Pituitary Adenylate Cyclase-Activating Polypeptide is a Potent Broad-Spectrum Antimicrobial Peptide: Structure-Activity Relationships

Por Starr, Charles G., Maderdrut, Jerome L., He, Jing, Coy, David H., Wimley, William C.
Publicado no Peptides (2018)

Somatostatin Receptor Type 2 Antagonism Improves Glucagon and Corticosterone Counterregulatory Responses to Hypoglycemia in Streptozotocin-Induced Diabetic Rats

Por Yue, Jessica T.Y., Burdett, Elena, Coy, David H., Giacca, Adria, Efendic, Suad, Vranic, Mladen
Publicado em 2012

Activated Notch signaling augments cell growth in hepatocellular carcinoma via up-regulating the nuclear receptor NR4A2

Por Zhu, Bo, Sun, Lichun, Luo, Wei, Li, Min, Coy, David H., Yu, Long, Yu, Wenbo
Publicado no Oncotarget (2017)

Isolation and structure of pro-methionine-enkephalin: Potential enkephalin precursor from porcine hypothalamus

Por Huang, Wei-Yong, Chang, Robert C. C., Kastin, Abba J., Coy, David H., Schally, Andrew V.
Publicado em 1979

Amelioration of Hypoglycemia Via Somatostatin Receptor Type 2 Antagonism in Recurrently Hypoglycemic Diabetic Rats

Por Yue, Jessica T.Y., Riddell, Michael C., Burdett, Elena, Coy, David H., Efendic, Suad, Vranic, Mladen
Publicado em 2013

HDAC inhibitors suppressed small cell lung cancer cell growth and enhanced the suppressive effects of receptor-targeting cytotoxins via upregulating somatostatin receptor II

Por Sun, Lichun, He, Quanyong, Tsai, Cheguo, Lei, Jun, Chen, Jing, Vienna Makcey, Lily, Coy, David H
Publicado no Am J Transl Res (2018)

Characterization of putative GRP and NMB-receptor antagonist's interaction with human receptors

Por González, Nieves, Mantey, Samuel A., Pradhan, Tapas K., Sancho, Veronica, Moody, Terry W., Coy, David H., Jensen, Robert T.
Publicado em 2009

Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): affinities, potencies and selectivity in multiple native and BnR transfected cells

Por Sancho, Veronica, Moody, Terry W., Mantey, Samuel A., Di Florio, Alessia, Uehara, Hirotsugu, Coy, David H., Jensen, Robert T.
Publicado em 2010

Comparative Pharmacology of Bombesin Receptor Subtype-3, Nonpeptide Agonist MK-5046, a Universal Peptide Agonist, and Peptide Antagonist Bantag-1 for Human Bombesin Receptors

Por Moreno, Paola, Mantey, Samuel A., Nuche-Berenguer, Bernardo, Reitman, Marc L., González, Nieves, Coy, David H., Jensen, Robert T.
Publicado em 2013

Pharmacology and selectivity of various natural and synthetic Bombesin related peptide agonists for human and rat bombesin receptors differs

Por Uehara, Hirotsugu, González, Nieves, Sancho, Veronica, Mantey, Samuel A., Nuche-Berenguer, Bernardo, Pradhan, Tapas, Coy, David H., Jensen, Robert T.
Publicado em 2011

The molecular basis for high affinity of a universal ligand for human bombesin receptor (BnR) family members

Por Uehara, Hirotsugu, Hocart, Simon J., González, Nieves, Mantey, Samuel A., Nakagawa, Tomoo, Katsuno, Tatsuro, Coy, David H., Jensen, Robert T.
Publicado em 2012

Pituitary adenylate cyclase-activating polypeptide prevents contrast-induced nephropathy in a novel mouse model

Por Khan, Altaf-M, Maderdrut, Jerome L, Li, Min, Toliver, Herman L, Coy, David H, Simon, Eric E, Batuman, Vecihi
Publicado em 2013

Notch Signaling Activation in Cervical Cancer Cells Induces Cell Growth Arrest with the Involvement of the Nuclear Receptor NR4A2

Por Sun, Lichun, Liu, Mingqiu, Sun, Guang-Chun, Yang, Xu, Qian, Qingqing, Feng, Shuyu, Mackey, L. Vienna, Coy, David H.
Publicado no J Cancer (2016)

Pituitary adenylate cyclase-activating polypeptide (PACAP) protects against mitoxantrone-induced cardiac injury in mice

Por Subramaniam, Venkat, Chuang, Gin, Xia, Huijing, Burn, Brendan, Bradley, Jessica, Maderdrut, Jerome L., Coy, David H., Varner, Kurt J.
Publicado no Peptides (2017)

Molecular basis for agonist selectivity and activation of the orphan BRS-3-receptor

Por Gonzalez, Nieves, Hocart, Simon J., Portal-Nuñez, Sergio, Mantey, Samuel A., Nakagawa, Tomoo, Zudaire, Enrique, Coy, David H., Jensen, Robert T.
Publicado em 2007